| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Troponin I, cardiac muscle|Cardiac troponin I|TNNI3|TNNC1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse cTnI/TNNI3 (Cardiac Troponin I) is a molecular target commonly studied in developmental biology, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of cTnI/TNNI3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of cTnI/TNNI3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
cTnI/TNNI3 (Cardiac Troponin I) may also be referenced as Troponin I, cardiac muscle, Cardiac troponin I, and TNNI3 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how cTnI/TNNI3 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in developmental biology, signal transduction, and neuroscience research.
- Interpreting shifts in cTnI/TNNI3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
cTnI/TNNI3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with developmental biology, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Mechanism of Nicotiflorin in San-Ye-Qing Rhizome for Anti-inflammatory Effect in Ulcerative Colitis
IF: 7.9 Journal: Phytomedicine Author: Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong University, NO.20, Xisi Road, Nantong 226001, Jiangsu, China Cited Date: 2024-03-29
MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway
IF: 5.8 Journal: Biochemical Pharmacology Author: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China; Fourth Department of Critical Care Medicine, Fujian Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, Fujian, China. Cited Date: 2024-04-07
Ameliorative effects of Danshensu from the functional food Salvia miltiorrhiza against arsenic trioxide-induced cardiac toxicity in vivo and in vitro: Involvement of inhibiting the AKT/IKK/NF-κB signaling pathway
IF: 5.223 Journal: Journal of Functional Foods Cited Date: 2022-10-27
ANXA4 Alleviates Cardiomyocyte Injury Associated With Ischemia–Reperfusion by Interfering With NFκB p50's Transcriptional Activation of RAGE
IF: 4.2 Journal: The FASEB Journal Author: Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, China. Cited Date: 2025-09-26
Neferine reduces synovial inflammation and cardiac complications in a collagen-induced arthritis mouse model via inhibiting NF-κB/NLRP3 inflammasome axis
IF: 3 Journal: Molecular Immunology Author: Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China. Cited Date: 2025-08-08
Downregulation of IFIT3 relieves the inflammatory response and myocardial fibrosis of mice with myocardial infarction and improves their cardiac function
IF: 1.574 Journal: Experimental Animals Cited Date: 2021-07-16
Pyrroloquinoline quinone protects against doxorubicin-induced cardiotoxicity in mice by modulating Nrf2 and NF-kB activities
IF: Journal: ScienceAsia Author: Yangfang Outpatient Department, The Northern Medical District, Chinese PLA General Hospital, Beijing 100094 China Cited Date: 2024-10-25